Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON–Recurrent Fracture Trial

被引：0

作者：

J. D. Adachi

K. W. Lyles

C. S. Colón-Emeric

S. Boonen

C. F. Pieper

C. Mautalen

L. Hyldstrup

C. Recknor

L. Nordsletten

K. A. Moore

C. Bucci-Rechtweg

G. Su

E. F. Eriksen

J. S. Magaziner

机构：

[1] McMaster University,St. Joseph’s Healthcare

[2] Duke University Medical Center and the Geriatrics Research Education and Clinical Center,undefined

[3] Veterans Affairs Medical Center,undefined

[4] University of Leuven,undefined

[5] Centro de Osteopatías Médicas,undefined

[6] Hvidovre Hospital,undefined

[7] United Osteoporosis Centers,undefined

[8] Ullevål University Hospital,undefined

[9] Novartis Pharmaceuticals Corporation,undefined

[10] Oslo University Hospital Aker,undefined

[11] University of Maryland,undefined

来源：

Osteoporosis International | 2011年 / 22卷

关键词：

EQ-5D; Health-related QoL; Low-trauma hip fracture; Zoledronic acid;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2539 / 2549

页数：10

共 50 条

[1] Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON-Recurrent Fracture Trial
Adachi, J. D.
Lyles, K. W.
Colon-Emeric, C. S.
Boonen, S.
Pieper, C. F.
Mautalen, C.
Hyldstrup, L.
Recknor, C.
Nordsletten, L.
Moore, K. A.
Bucci-Rechtweg, C.
Su, G.
Eriksen, E. F.
Magaziner, J. S.
OSTEOPOROSIS INTERNATIONAL, 2011, 22 (09) : 2539 - 2549
[2] ZOLEDRONIC ACID IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HIP FRACTURE: RESULTS OF HORIZON-RFT
Adachi, Jonathan
Bucci-Rechtweg, C.
Su, G.
Eriksen, Erik
Magaziner, Jay
Lyles, Kenneth
Colonemeric, Cathleen
Boonen, Steven
Pieper, C.
Mautalen, Carlos
Hyldstrup, Lars
Recknor, Christopher
Nordsletten, L.
OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 140 - 142
[3] ZOLEDRONIC ACID IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HIP FRACTURE: RESULTS OF HORIZON-RFT
Adachi, J. D.
Lyles, K. W.
Colon-Emeric, C. S.
Boonen, S.
Pieper, C. F.
Mautalen, C.
Hyldstrup, L.
Recknor, C.
Nordsletten, L.
Bucci-Rechtweg, C.
Su, G.
Eriksen, E. F.
Magaziner, J. S.
OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 151 - 151
[4] Evaluation of health-related quality of life following hip fracture
Vatansever, A
Öziç, U
Okcu, G
OSTEOPOROSIS INTERNATIONAL, 2004, 15 (07) : 587 - 587
[5] EFFECT OF ONCE-YEARLY ZOLEDRONIC ACID IN MEN AFTER RECENT HIP FRACTURE: RESULTS FROM HORIZON RECURRENT FRACTURE TRIAL
Boonen, Steven
Kaufmann, Jean-Marc
Orwoll, Eric
Magaziner, Jay
Colon-Emeric, Cathleen
Adachi, Rick
Bucci-Rechtweg, Christina
Haentjhens, Patrick
Vanderschueren, Dirk
Lyles, Kenneth
OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 180 - 180
[6] EFFECT OF ONCE-YEARLY IV ZOLEDRONIC ACID IN MEN AFTER HIP FRACTURE: RESULTS FROM THE HORIZON-RECURRENT FRACTURE TRIAL
Boonen, S.
Magaziner, J.
Lyles, K.
Colon-Emeric, C.
Adachi, J.
Bucci-Rechtweg, C.
Mesenbrink, P.
OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 84 - 84
[7] EFFECT OF ONCE-YEARLY IV ZOLEDRONIC ACID IN MEN AFTER HIP FRACTURE: RESULTS FROM THE HORIZON-RECURRENT FRACTURE TRIAL
Boonen, S.
Magaziner, J.
Lyles, K. W.
Dennison, E.
Colon-Emeric, C.
Adachi, J. D.
Bucci-Rechtweg, C.
Mesenbrink, P.
OSTEOPOROSIS INTERNATIONAL, 2009, 20 : S271 - S272
[8] MEASURING HEALTH-RELATED QUALITY OF LIFE IN HIP FRACTURE - A PILOT STUDY
Lewis, S.
Edwards, L.
Glasbey, J.
Johansen, A.
AGE AND AGEING, 2017, 46
[9] Zoledronic acid reduces recurrent clinical fracture in patients with hip fracture
Stuart L. Silverman
Current Osteoporosis Reports, 2009, 7 (1) : 1 - 2
[10] Efficacy and safety of zoledronic acid 5 mg in preventing fractures in men and women with prevalent hip fracture: The HORIZON-Recurrent Fracture Trial
Lyles, K.
Colon-Emeric, C.
Magaziner, J.
Adachi, J.
Pieper, C.
Hyldstrup, L.
Mautalen, C.
Recknor, C.
Moore, K.
Lavecchia, C.
Zhang, J.
Mesenbrink, P.
Eriksen, E.
Boonen, S.
JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S16 - S16

← 1 2 3 4 5 →